| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |